Compare Newmont Corporation (NEM) vs Revolution Medicines Inc. Common Stock (RVMD) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Newmont Corporation vs Revolution Medicines Inc. Common Stock — how do they compare? Newmont Corporation trades at $118.37 (market cap $121.75B), while Revolution Medicines Inc. Common Stock trades at $191.04 (market cap $40.32B). The key difference: Newmont Corporation is far larger — about 3× Revolution Medicines Inc. Common Stock's market cap, and Newmont Corporation pays a 0.9% dividend while Revolution Medicines Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Newmont Corporation for 58 Days and Revolution Medicines Inc. Common Stock for 0 Days on average.
| NEM | RVMD | |
|---|---|---|
Market Cap | $121.75B | $40.32B |
Volume | 5,421,125 | 4,855,734 |
Sector | Basic Materials | Health |
52-Week High | $135.14 | $221.15 |
52-Week Low | $78.63 | $47.50 |
Typical Hold Time | 58 Days | 0 Days |
Enterprise Value | $118.34B | $37.02B |
Dividend Yield | 0.9% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Newmont (NEM) trades at $118.23, up 4.13% today, supported by strong earnings beats and record free cash flow. The stock shows a bearish technical signal near key support at $114, while fundamentals are robust with a P/E of 14.57, net income margin of 33.36%, and revenue growth to $22.67B in 2025. Analyst consensus is strongly bullish with a $136.83 price target.
The outlook for NEM is positive, driven by operational improvements and a constructive gold market. Key risks include gold price volatility and execution of growth projects. With no analyst sell ratings and strong institutional interest, the stock presents a compelling opportunity for investors seeking exposure to a leading gold producer.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Newmont Corporation
Newmont Corp is primarily a gold producer with operations and/or assets in the United States, Canada, Mexico, Dominican Republic, Peru, Suriname, Argentina, Chile, Australia, and Ghana. It is also engaged in the production of copper, silver, lead and zinc. The company's operations are organized in five geographic regions: North America, South America, Australia, Africa and Nevada.
Read more on NEM →About Revolution Medicines Inc. Common Stock
Revolution Medicines develops precision medicines for cancer. Its programs focus on targeting RAS-driven cancers and related signaling pathways.
Read more on RVMD →
